EP 0874637 A1 19981104 - THERAPEUTIC APPLICATIONS OF T-BAM (CD40L) TECHNOLOGY TO TREAT INFLAMMATORY KIDNEY DISEASES
Title (en)
THERAPEUTIC APPLICATIONS OF T-BAM (CD40L) TECHNOLOGY TO TREAT INFLAMMATORY KIDNEY DISEASES
Title (de)
Therapeutische Anwendungen des CD40L Systems zur Behandlungvon entzündlichen Nierenerkrankungen
Title (fr)
APPLICATIONS DES TECHNIQUES T-BAM (CD40L) A DES FINS THERAPEUTIQUES, POUR LE TRAITEMENT D'AFFECTIONS RENALES INFLAMMATOIRES
Publication
Application
Priority
- US 9700668 W 19970116
- US 58733496 A 19960116
- US 64147396 A 19960501
Abstract (en)
[origin: WO9726000A1] Activation by CD40 ligand of renal cells bearing CD40 on the cell surface is inhibited, both in vivo and ex vivo, with an agent capable of inhibiting interaction between CD40 ligand and CD40 on the cells. Inflammatory kidney diseases are treated.
IPC 1-7
IPC 8 full level
G01N 33/566 (2006.01); A61K 31/00 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61P 13/00 (2006.01); A61P 13/12 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C12N 5/00 (2006.01); C12N 15/02 (2006.01); C12P 21/08 (2006.01); G01N 33/15 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP)
A61P 13/00 (2017.12); A61P 13/12 (2017.12); C07K 14/70575 (2013.01); C07K 14/70578 (2013.01); C07K 16/2875 (2013.01); C07K 16/2878 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9726000A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9726000 A1 19970724; AU 1748897 A 19970811; CA 2243531 A1 19970724; EP 0874637 A1 19981104; JP 2000503659 A 20000328; MX 9805724 A 19981031
DOCDB simple family (application)
US 9700668 W 19970116; AU 1748897 A 19970116; CA 2243531 A 19970116; EP 97904780 A 19970116; JP 52617497 A 19970116; MX 9805724 A 19980716